Related Experiment Video
Updated: Mar 1, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Therapeutic targeting of autophagy in myocardial infarction and heart failure
Jaime A Riquelme1, Myra N Chavez1,2, David Mondaca-Ruff1
1a Advanced Center for Chronic Disease (ACCDiS) & Center for Molecular Studies of the Cell (CEMC), Facultad de Ciencias Químicas y Farmacéuticas & Facultad de Medicina , Universidad de Chile , Santiago , Chile.
Insights
Targeting autophagy, a cellular process, shows promise for treating myocardial infarction (MI) and heart failure (HF). Myocardial-specific strategies are needed to avoid systemic side effects in clinical trials.
Area of Science:
- Cardiovascular Medicine
- Cellular Biology
- Molecular Medicine
Background:
- Myocardial infarction (MI) is a primary cause of mortality.
- Heart failure (HF) frequently follows non-lethal MI, presenting a significant clinical challenge.
- Autophagy modulation is an emerging therapeutic strategy for MI and HF.
Purpose of the Study:
- To review the current understanding of autophagy's role in MI and HF.
- To explore pharmacological and genetic approaches for modulating autophagy.
- To discuss the potential of autophagy targeting in myocardial regeneration.
Main Methods:
- Comprehensive PubMed literature search.
- Review of existing research on autophagy in cardiovascular diseases.
- Analysis of therapeutic strategies for autophagy modulation.
Main Results:
- Autophagy plays a critical role in the pathophysiology of MI and HF.
- Pharmacological and genetic interventions can modulate autophagy.
- Targeting autophagy may aid in myocardial regeneration.
Conclusions:
- Autophagy modulation holds significant therapeutic potential for MI and HF.
- Development of myocardium-specific autophagy targeting strategies is crucial for clinical translation.
- Further research is needed to optimize autophagy-based therapies for cardiovascular diseases.
Introduction:
Myocardial infarction (MI) is the leading cause of death. When MI is not lethal, heart failure (HF) is a major consequence with high prevalence and poor prognosis. The targeting of autophagy represents a potentially therapeutic approach for the treatment of both pathologies.
Areas Covered:
PubMed searches were performed to discuss the current state of the art regarding the role of autophagy in MI and HF. We review available and potential approaches to modulate autophagy from a pharmacological and genetic perspective. We also discuss the targeting of autophagy in myocardial regeneration. Expert commentary: The targeting of autophagy has potential for the treatment of MI and HF. Autophagy is a process that takes place in virtually all cells of the body and thus, in order to evaluate this therapeutic approach in clinical trials, strategies that specifically target this process in the myocardium is required to avoid unwanted effects in other organs.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Myocarditis III: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Inotropic Agents
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

